Linzess was launched in the United States in January 2013 [1].
When is Linzess patent expiration expected?
The patent exclusivity for Linzess is scheduled to expire in 2026 [2]. However, there are ongoing legal challenges and potential for extended market protection through various mechanisms, including patent litigation and new formulation patents [2].
What are the key patents protecting Linzess?
Linzess is protected by several patents. The primary patents cover the active pharmaceutical ingredient, linaclotide, and its methods of use [3]. For instance, U.S. Patent No. 7,112,616, which is set to expire in 2026, is a significant patent for linaclotide [2]. Additional patents may cover specific formulations or dosage forms of the drug.
Are there any ongoing patent disputes for Linzess?
Yes, there are active patent disputes involving Linzess. Generic manufacturers are challenging the validity of key patents, which could lead to earlier market entry for generic versions [4]. These challenges are common for successful branded drugs as their patent protection nears its end.
What happens if Linzess patents are invalidated?
If key patents for Linzess are invalidated in court, it could pave the way for generic versions of the drug to be approved and marketed by the U.S. Food and Drug Administration (FDA) sooner than the original expiry date of 2026 [4]. This would likely lead to increased competition and potentially lower prices for the medication.
How does Linzess work for irritable bowel syndrome with constipation (IBS-C)?
Linzess works by activating guanylate cyclase-C (GC-C) on the surface of intestinal cells [5]. This activation increases the secretion of chloride and bicarbonate into the intestinal lumen, which leads to increased fluid in the intestines [5]. Linaclotide also accelerates intestinal transit time and reduces visceral pain, addressing key symptoms of IBS-C [5].
Who are the main competitors to Linzess?
Other medications approved for the treatment of IBS-C include drugs like Amitiza (lubiprostone) and certain laxatives [6]. These competitors offer alternative mechanisms of action for managing the symptoms of IBS-C.
What is the typical cost of Linzess?
The cost of Linzess can vary significantly based on insurance coverage, pharmacy, and dosage. Without insurance, a 30-day supply can cost several hundred dollars [7]. Patients may be eligible for manufacturer discount programs to help offset the cost.
Where can I find more information on Linzess patents?
Information on Linzess patents, including their expiration dates and any related litigation, can often be found on specialized drug patent tracking websites such as DrugPatentWatch.com [2][3].
What are the common side effects of Linzess?
The most common side effect associated with Linzess is diarrhea [1]. Other potential side effects include bloating, abdominal pain, and gas [1]. Patients experiencing severe or persistent diarrhea should consult their healthcare provider.